Gujarat Themis Biosyn Stock Soars to All-Time High, Signaling Market Dominance

Gujarat Themis Biosyn has achieved a significant milestone by reaching an all-time high on October 27, 2025. This remarkable achievement underscores the company's strong performance in the pharmaceuticals and biotechnology sector.
Despite a slight underperformance today compared to the sector, Gujarat Themis Biosyn has shown resilience with a 0.27% increase in its stock price. Over the past month, the stock has surged by 14.49%, significantly outpacing the Sensex's 5.47% gain. The company's performance over the last year has been particularly impressive, with a 60.33% increase compared to the Sensex's 6.83%.

Gujarat Themis Biosyn's stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. The small-cap company has demonstrated exceptional growth over the long term, with a staggering 5-year performance of 1312.39% and a remarkable 10-year performance of 5439.77%. This all-time high reflects the company's robust market position and consistent growth trajectory in the competitive pharmaceuticals and biotechnology industry.